Literature DB >> 8096488

Cloning of the mouse cDNA encoding DNA topoisomerase I and chromosomal location of the gene.

O Koiwai1, Y Yasui, Y Sakai, T Watanabe, K Ishii, S Yanagihara, T Andoh.   

Abstract

The mouse cDNA encoding DNA topoisomerase I (TopoI) was cloned and the nucleotide sequence of 3512 bp was determined. The cDNA clone contained an open reading frame encoding a protein of 767 amino acids (aa), which is 2 aa longer than its human counterpart. Overall aa sequence homology between the mouse and human, and between the mouse and yeast (Saccharomyces cerevisiae) sequences was 96% and 42%, respectively. The mouse TopI gene was mapped at position 54.5 on chromosome 2 from linkage analyses of a three-point cross test with Geg, Ada, and a as marker genes.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8096488     DOI: 10.1016/0378-1119(93)90331-v

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  6 in total

1.  Targeted disruption of the mouse topoisomerase I gene by camptothecin selection.

Authors:  S G Morham; K D Kluckman; N Voulomanos; O Smithies
Journal:  Mol Cell Biol       Date:  1996-12       Impact factor: 4.272

Review 2.  Antinuclear autoantibodies: probes for defining proteolytic events associated with apoptosis.

Authors:  C A Casiano; E M Tan
Journal:  Mol Biol Rep       Date:  1996       Impact factor: 2.316

3.  Genetic mapping of DNA topoisomerase I-related sequences to mouse chromosomes 2 and 14.

Authors:  S F Kingsmore; C K Lo; J Hwang; C F Hui; M F Seldin
Journal:  Mamm Genome       Date:  1994-04       Impact factor: 2.957

4.  T cell proliferative response induced by DNA topoisomerase I in patients with systemic sclerosis and healthy donors.

Authors:  M Kuwana; T A Medsger; T M Wright
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

5.  Mouse genes encoding DNA topoisomerase I.

Authors:  B Baumgärtner; C Klett; H Hameister; A Richter; R Knippers
Journal:  Mamm Genome       Date:  1994-01       Impact factor: 2.957

6.  Suppression of lupus nephritis and skin lesions in MRL/lpr mice by administration of the topoisomerase I inhibitor irinotecan.

Authors:  Andreas Keil; Sean R Hall; Meike Körner; Martin Herrmann; Ralph A Schmid; Steffen Frese
Journal:  Arthritis Res Ther       Date:  2016-10-22       Impact factor: 5.156

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.